Back to Market Feed

Product Information

ENTECAVIR 0.5 MG TABLET is a generic product labeled by Cameron Pharmaceuticals, priced at $0.2134 per EA under NDC 42494045730. Its NADAC has been published 52 times since Aug 27, 2025.

FDA first approved this application on Dec 23, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENTECAVIR 0.5 MG TABLET

ENTECAVIR ANHYDROUS
$0.2134per EA

Strength

.5 mg/1

NDC

42494045730

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ENTECAVIR ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216857

FDA Approved

12/23/2024

TE Code

AB

On Market Since

5/15/2025

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ENTECAVIR 0.5 MG TABLET has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2134 per EA
All-time high$0.2640 (Oct 15, 2025)
All-time low$0.2096 (May 20, 2026)
52-week high$0.2640
52-week low$0.2096
Median price$0.2218
Average price$0.2284
Largest weekly change-8.5% (Oct 22, 2025)
Weeks tracked52
Tracking sinceAug 27, 2025

Price History

1W

+0.1%

1M

+0.1%

3M

+1.8%

6M

-9.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-18.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ENTECAVIR ANHYDROUS market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

ACYCLOVIR 200 MG/5 ML SUSP
Generic
00472008216•Actavis Pharma, Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
31722068147•Camber Pharmaceuticals Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
62135080347•Chartwell RX LLC
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
70954018810•ANI Pharmaceuticals, Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72205017072•Novadoz Pharmaceuticals LLC
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72888007917•Advagen Pharma Ltd.
$0.0694
per ML
ACYCLOVIR 400 MG TABLET
Generic
75834012201•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 400 MG TABLET
Generic
75834012205•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 200 MG CAPSULE
Generic
75834012401•Nivagen Pharmaceuticals Inc.
$0.0971
per EA
ACYCLOVIR 200 MG CAPSULE
Generic
00904578961•Major Pharmaceuticals
$0.0973
per EA

Frequently asked questions

What is the NADAC price of ENTECAVIR 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Cameron Pharmaceuticals, is $0.2134 per EA (NDC 42494045730), effective Aug 19, 2026.

How has the price of ENTECAVIR 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 18.7%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?

Since Aug 27, 2025, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $0.2640 (Oct 15, 2025), with a median of $0.2218 per EA.

Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ENTECAVIR 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ENTECAVIR 0.5 MG TABLET?

ENTECAVIR 0.5 MG TABLET (NDC 42494045730) is labeled by Cameron Pharmaceuticals, and CMS classifies it as a generic product.